Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
PMCBCompany Name
PHARMACYTE BIOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPHARMACYTE BIOTECH INC - Price to Earnings Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PMCB - P/E Historical data
| Date | Market Capitalization | Net Income Common Stock | Price to Earnings |
|---|---|---|---|
| 6/30/2025 | $ 7M | $ -5.59M | 0 |
| 3/31/2025 | $ 5.95M | $ 23.36M | 0.25 |
| 12/31/2024 | $ 10.84M | $ 12.04M | 0.9 |
| 9/30/2024 | $ 11.99M | $ 9.47M | 1.27 |
| 6/30/2024 | $ 14.44M | $ 10.17M | 1.42 |
| 3/31/2024 | $ 14.26M | $ -17.24M | 0 |
| 12/31/2023 | $ 17.01M | $ -11.51M | 0 |
| 9/30/2023 | $ 18.52M | $ -6.65M | 0 |
| 6/30/2023 | $ 21.86M | $ -6.27M | 0 |
| 3/31/2023 | $ 23.35M | $ -4.32M | 0 |
Key Performance Insights, Last 5 Years
- PHARMACYTE BIOTECH INC's latest trailing twelve months (TTM) P/E stands at 0.
- Over the past 5 years, PHARMACYTE BIOTECH INC's average P/E has been 0.96.
- The median P/E for PHARMACYTE BIOTECH INC during this period was 1.08
- PHARMACYTE BIOTECH INC reached its highest P/E over the past 5 years at 1.42.
- The lowest P/E recorded by PHARMACYTE BIOTECH INC in the same timeframe 0.25
Similar metrics to P/E:
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Price to Earnings
[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.Market Cap / Net Inc. Cmn.
(=) P/E P/E for PHARMACYTE BIOTECH INC is calculated as follows: Market Cap [ $ 13.03M ] / Net Inc. Cmn. [ $ -3.46M ]
(=) P/E [ 0 ] PMCB - Price to Earnings, Last 5 years
0.25
Minimum
Mar 31, 2025
1.42
Maximum
Jun 30, 2024
0.96
Average
1.08
Median
P/E Benchmark AnalysisMarket
The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.52 with a standard deviation of 13.95.
The following table provides additional summary stats:
P/E in the Market:
| filtered constituents | 2.07K |
|---|---|
| min | 0.13 |
| max | 70.11 |
| average | 22.52 |
| median | 18.89 |
| std | 13.95 |